Ultragenyx Pharmaceutical Inc (RARE)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$23.13
Buy
$23.16
$0.71 (+3.17%)
Prices updated at 04 Jun 2026, 18:57 EDT
| Prices minimum 15 mins delay
Prices in USD
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic con ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Most recent dividend payment
| - | |
| - | |
| - | |
| - | |
| - | |
| - |
Total dividend yield
No data available
Dividend history and forecast data table
| Year | Dividend per share | Dividend growth (%) |
|---|---|---|
| 2026 | - | - |
| 2025 | - | - |
| 2024 | - | - |
| 2023 | - | - |
| 2022 | - | - |
| 2021 | - | - |
| 2020 | - | - |
| 2019 | - | - |
| 2018 | - | - |
| 2017 | - | - |
Total dividend yield data table
Year | Dividend yield (%) | Buyback yield (%) |
|---|---|---|
| 2026 | - | - |
| 2025 | - | - |
| 2024 | - | - |
| 2023 | - | - |
| 2022 | - | - |
| 2021 | - | - |
| 2020 | - | - |
| 2019 | - | - |
| 2018 | - | - |
| 2017 | - | - |
Dividend per share
No data available
% of earnings paid to shareholders
No data available
Dividend per share data table
| Year | Dividend per share |
|---|---|
| 2026 | - |
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
% of earnings paid to shareholders data table
| Year | Payout ratio (%) |
|---|---|
| 2026 | - |
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
Latest Financial Report as of 03 Jun 2026
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.
